Publications by authors named "Judit Demeter"

Claim this Profile
E
Expert consensus opinion on the management of hairy cell leukemia in elderly patients.
Tamar Tadmor, Judit Demeter, Andrei Fagarasanu, Robert J Kreitman, Sameer A Parikh

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of hairy cell leukaemia with pegylated interferon-alpha-2A.
Kata Ferenczi, Zsófia Flóra Nagy, Ildikó Istenes, Hanna Eid, Csaba Bödör, Judit Demeter

Pathol Oncol Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Importance of high-throughput genetic investigations in the differential diagnosis of unexplained erythrocytosis.
Zsófia Flóra Nagy, György Pfliegler, János Kósa, Kristóf Árvai, Ildikó Istenes, Judit Demeter

Pathol Oncol Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Comprehensive clinical, pathological and genetic investigations to decipher the background of cyclic thrombocytopenia.
Zsófia Flóra Nagy, Kristóf Árvai, Péter Lakatos, Ildikó Beke Debreceni, Balázs Szili, Judit Demeter

Pathol Oncol Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study.
Christopher R Flowers, Matthew J Matasar, Alex F Herrera, Mark Hertzberg, Sarit Assouline, Judit Demeter

Haematologica· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary.
Peter Batar, Hussain Alizadeh, Gyorgy Rokszin, Zsolt Abonyi-Toth, Judit Demeter

Pathol Oncol Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary.
Peter Batar, Hussain Alizadeh, Gyorgy Rokszin, Zsolt Abonyi-Toth, Judit Demeter

Pathol Oncol Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.
Tamás László, Lili Kotmayer, Viktória Fésüs, Lajos Hegyi, Stefánia Gróf, Judit Demeter

J Pathol Clin Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long term follow-up of refractory/relapsed hairy cell leukaemia patients treated with low-dose vemurafenib between 2013 and 2022 at the Department of Internal Medicine and Oncology, Semmelweis University.
Kata Ferenczi, Zsófia Flóra Nagy, Ildikó Istenes, Hanna Eid, Csaba Bödör, Judit Demeter

Pathol Oncol Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma.
Ákos Nagy, Bence Bátai, Laura Kiss, Stefánia Gróf, Péter Attila Király, Judit Demeter

J Intern Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study.
Pierre Fenaux, Marco Gobbi, Patricia L Kropf, Jean-Pierre J Issa, Gail J Roboz, Judit Demeter

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A potentially new thromboembolic event scoring system in polycythaemia vera patients: An audit of the Hungarian Philadelphia negative chronic myeloproliferative neoplasia register.
Eva Karadi, Peter Dombi, Viktoria Gyorine Korom, Eszter Kovacs, Jozsef Herczeg, Judit Demeter

Eur J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Beta-thalassemia and vitamin B12 deficiency and associated complement-mediated hemolysis].
Ákos Géza Pethő, Zsófia Flóra Nagy, Zoltán András Mezei, István Takács, Judit Demeter

Orv Hetil· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of BT595 (10% human intravenous immunoglobulin) in adult patients with chronic immune thrombocytopenia.
Judit Demeter, Aryan Hamed, Szerafin László, Nada Suvajdzic, Silke Aigner

Transfus Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Landscape of Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax.
Lili Kotmayer, Tamás László, Gábor Mikala, Richárd Kiss, Luca Lévay, Judit Demeter

Int J Mol Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope.
Maria Ilaria Del Principe, Danila Seidel, Marianna Criscuolo, Michelina Dargenio, Zdenek Rácil, Judit Demeter

Mycoses· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a distributed international patient data registry for hairy cell leukemia.
Leslie A Andritsos, Mirela Anghelina, Jasmine Neal, James S Blachly, Puneet Mathur, Judit Demeter

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia.
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Judit Demeter

Blood Cancer J· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry.
Ferenc Takács, Lili Kotmayer, Ágnes Czeti, Gábor Szalóki, Tamás László, Judit Demeter

Pathol Oncol Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy.
Amer M Zeidan, Pierre Fenaux, Marco Gobbi, Jiří Mayer, Gail J Roboz, Judit Demeter

Blood· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Development of Diffuse Large B Cell Lymphoma a Long Time After Hairy Cell Leukemia.
Zsófia F Nagy, Kata Ferenczi, Ildikó Istenes, Hanna Eid, Csaba Bödör, Judit Demeter

Pathol Oncol Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Long-time progression-free survival in relapsed, refractory multiple myeloma with the oral ixazomib-lenalidomide-dexamethasone regime].
Apor Hardi, Gergely Varga, Zsolt Nagy, Szabolcs Kosztolányi, László Váróczy, Judit Demeter

Orv Hetil· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Case report of amyloid light-chain amyloidosis with periocular cutaneous involvement].
Csilla Haász, Enikő Kuroli, Pálma Anker, Dalma Fanni Márton, Ágnes Szigeti, Judit Demeter

Orv Hetil· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Retrospective analysis of chronic myeloid leukemia patients treated in the Department of Internal Medicine and Oncology, Semmelweis University, between 2003 and 2019].
Júlia Weisinger, Ilona Tárkányi, Eid Hanna, Ágnes Kárpáti, Zsolt Nagy, Judit Demeter

Orv Hetil· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia].
Ágnes Fehér, Ildikó Istenes, Júlia Weisinger, Péter Király, Anna Rakonczai, Judit Demeter

Orv Hetil· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis